Abstract
Inefficient alternative splicing of the human immunodeficiency virus type 1(HIV-1) primary RNA transcript results in greater than half of all viral mRNA remaining unspliced. Regulation of HIV-1 alternative splicing occurs through the presence of suboptimal viral 5' and 3' splice sites (5' and 3'ss), which are positively regulated by exonic splicing enhancers (ESE) and negatively regulated by exonic splicing silencers (ESS) and intronic splicing silencers (ISS). We previously showed that splicing at HIV-1 3'ss A2 is repressed by ESSV and enhanced by the downstream 5'ss D3 signal. Disruption of ESSV results in increased vpr mRNA accumulation and exon 3 inclusion, decreased accumulation of unspliced viral mRNA, and decreased virus production. Here we show that optimization of the 5'ss D2 signal results in increased splicing at the upstream 3'ss A1, increased inclusion of exon 2 into viral mRNA, decreased accumulation of unspliced viral mRNA, and decreased virus production. Virus production from the 5'ss D2 and ESSV mutants was rescued by transient expression of HIV-1 Gag and Pol. We further show that the increased inclusion of either exon 2 or 3 does not significantly affect the stability of viral mRNA but does result in an increase and decrease, respectively, in HIV-1 mRNA levels. The changes in viral mRNA levels directly correlate with changes in tat mRNA levels observed upon increased inclusion of exon 2 or 3. These results demonstrate that splicing at HIV-1 3'ss A1 is regulated by the strength of the downstream 5'ss signal and that suboptimal splicing at 3'ss A1 is necessary for virus replication. Furthermore, the replication defective phenotype resulting from increased splicing at 3'ss A1 is similar to the phenotype observed upon increased splicing at 3'ss A2. Further examination of the role of 5'ss D2 and D3 in the alternative splicing of 3'ss A1 and A2, respectively, is necessary to delineate a role for non-coding exon inclusion in HIV-1 replication.
MeSH Terms
Alternative Splicing
Base Sequence
Cell Line
DNA Primers
Enhancer Elements, Genetic
Exons
Gene Products, vif/immunology
Gene Products, vpr/immunology
HIV-1/genetics,physiology
HeLa Cells
Humans
Molecular Sequence Data
Oligonucleotides, Antisense
Plasmids
RNA, Messenger/genetics
RNA, Viral/genetics
Virus Replication
vif Gene Products, Human Immunodeficiency Virus
vpr Gene Products, Human Immunodeficiency Virus
Chemicals
DNA Primers
Gene Products, vif
Gene Products, vpr
Oligonucleotides, Antisense
RNA, Messenger
RNA, Viral
vif Gene Products, Human Immunodeficiency Virus
vpr Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Madsen Joshua M
Interdisciplinary Program in Molecular Biology, University of Iowa, Iowa City, IA 52242, USA.
[email protected]
Stoltzfus C Martin
References (26)
26 references, click to expand
-
Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Gene Ther. 1995 Jun;2(4):269-78
PMID: 7552987
-
Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
Virology. 1995 Nov 10;213(2):373-85
PMID: 7491762
-
Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
Nucleic Acids Res. 1997 Feb 15;25(4):861-7
PMID: 9016638
-
Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
Gene Ther. 1999 May;6(5):715-28
PMID: 10505094
-
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.
J Biol Chem. 2005 Mar 4;280(9):8581-8
PMID: 15611123
-
Determinants of the inherent strength of human 5' splice sites.
RNA. 2005 May;11(5):683-98
PMID: 15840817
-
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
Immunity. 2005 May;22(5):607-19
PMID: 15894278
-
An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
J Virol. 2005 Aug;79(16):10478-86
PMID: 16051840
-
Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
J Virol. 1999 Dec;73(12):9764-72
PMID: 10559286
-
Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.
Nucleic Acids Res. 2001 Jan 15;29(2):464-78
PMID: 11139617
-
The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
RNA. 2001 Mar;7(3):421-34
PMID: 11333022
-
Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Virology. 2001 Aug 1;286(2):276-89
PMID: 11485396
-
RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
J Virol. 2001 Sep;75(18):8487-97
PMID: 11507194
-
The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
EMBO J. 2001 Oct 15;20(20):5748-58
PMID: 11598017
-
Functional analysis of the interaction of the human immunodeficiency virus type 1 Rev nuclear export signal with its cofactors.
Virology. 2003 Sep 30;314(2):591-600
PMID: 14554087
-
SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
J Biol Chem. 2004 Mar 12;279(11):10077-84
PMID: 14703516
-
A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
J Virol. 2004 Jun;78(12):6517-26
PMID: 15163745
-
Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
J Virol. 2004 Oct;78(20):11130-41
PMID: 15452233
-
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J Virol. 1986 Aug;59(2):284-91
PMID: 3016298
-
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
J Virol. 1988 Jan;62(1):139-47
PMID: 3257102
-
Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
J Virol. 1993 Nov;67(11):6365-78
PMID: 8411338
-
The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
J Virol. 1994 May;68(5):3071-9
PMID: 7512159
-
Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
Mol Cell Biol. 1994 Jun;14(6):3960-70
PMID: 8196635
-
Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction.
AIDS Res Hum Retroviruses. 1994 Nov;10(11):1531-42
PMID: 7888208
-
Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
Mol Cell Biol. 1995 Aug;15(8):4597-605
PMID: 7623851
-
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
Mol Cell Biol. 1995 Aug;15(8):4606-15
PMID: 7623852